Match tier Listed
Presence Current · Arkansas
Last published 2023
Sources OpenAlex · ORCID
Refreshed 2026-08-18

R. Scicali

Researcher

Also affiliated: Ospedale Garibaldi (2022)

Graduate Student Researcher

3 pubs

Biography and Research Information

OverviewAI-generated summary

R. Scicali's research investigates the role of proprotein convertase subtilisin kexin type 9 (PCSK9) inhibitors in managing familial hypercholesterolemia. Their work has explored how these inhibitors affect platelet net release, a factor contributing to thrombosis in individuals with this genetic condition. Additionally, Scicali has examined the impact of PCSK9 inhibition on serum lipoprotein functions in patients diagnosed with homozygous familial hypercholesterolemia, including cases with delayed diagnosis. This research contributes to understanding the broader implications of PCSK9 inhibition beyond cholesterol reduction, focusing on its potential to mitigate thrombotic risks and improve lipid profiles in specific patient populations.

Metrics

  • Publications: 3

Selected Publications

  • OC 10.4 Proprotein Convertase Subtilisin Kexin Type 9 Inhibitors Reduce Platelet Nets Release Driver Thrombosis in Familial Hypercholesterolemia (2023)
    Research and Practice in Thrombosis and Haemostasis DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

14 Collaborators 9 Institutions 3 Countries

Top Collaborators

Similar Researchers

Based on overlapping research topics